Metraipolis › archive › dc_6f428690b96d
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration — Europe PMC PMID:41905770
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41905770
- DOI
- 10.1111/bjh.70458
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T17:37:16.736Z
- SHA-256 of the archived text
3a74465bbb0bd888d2b5f60aafcb9bdc7cfa5e5eb4e788ebc50feb10a77dfdea- Stable URL of this page
https://metraipolis.com/documento/dc_6f428690b96d
How to cite
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration — Europe PMC PMID:41905770 — Europe PMC (en), https://europepmc.org/article/MED/41905770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f428690b96d (Metraipolis archive dc_6f428690b96d, sha256 3a74465bbb0bd888d2b5f60aafcb9bdc7cfa5e5eb4e788ebc50feb10a77dfdea)
BibTeX
@misc{dc6f428690b96d,
title = {Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration — Europe PMC PMID:41905770},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41905770},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f428690b96d; sha256 3a74465bbb0bd888d2b5f60aafcb9bdc7cfa5e5eb4e788ebc50feb10a77dfdea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41905770. Agents can read the archived copy with the MCP tool read_document.